The chemical arts are inherent in a wide variety of industry sectors. Woodcock Washburn enhances the patent position of companies involved in making or selling industrial chemicals, pharmaceuticals, ceramics, agricultural chemicals, drug delivery depots, small molecules, polymers, metal coatings, alloys, petrochemicals, personal care products, paints, medical implants, electronics, food products, and adhesives.
Woodcock Washburn represents well-established corporations, such as Johnson & Johnson, DuPont, Henkel, and GKN Sinter Metals, as well as startup companies and universities. Our firm's attorneys hold advanced degrees in organic chemistry, biochemistry, biology, microbiology, and chemical engineering, making us thoroughly familiar with the established strategies within various industries and able to inject fresh thinking. Some of us previously worked for organizations such as Bell Laboratories, the University of Pennsylvania, DuPont, FMC, Rohm and Haas, and General Electric.
The firm counsels startups and smaller companies on educating their scientists on the basics of patent law, developing patent and trademark portfolio strategies, surveying the competitive landscape, and staking out their territories. We also frequently assist in licensing the technology and, in some instances, navigating the federal regulatory pathways. Our attorneys advise large clients on how to handle the prosecution of specific cases or patent families that are particularly important or complex, or that require specialized expertise. For example, our familiarity with the nuances of the Hatch-Waxman Act is very useful to companies in the pharmaceutical industry.
Woodcock Washburn's expertise covers small molecule therapeutics, reaction catalysts, chemical compositions, biochemistry, environmental processes, and molecular biology. We provide intellectual property strategy and planning services, opinions, clearance and right-to-use studies, U.S. and foreign patent preparation and prosecution, appeals and, where appropriate, application guidance through interference, reexamination or reissue.
Some of our recent litigations in this area are: